Trials / Completed
CompletedNCT00036283
Chemoprevention of Oral Premalignant Lesions
Clinical Protocol For A Phase II Double-Blind, Placebo-Controlled, Randomized Study Of Celecoxib (Sc-58635) In Oral Premalignant Lesions, Investigator IND
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 42 (planned)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Reduction in size and number of oral premalignant lesions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Celecoxib |
Timeline
- Start date
- 2000-11-01
- Completion
- 2004-04-01
- First posted
- 2002-05-09
- Last updated
- 2008-09-29
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00036283. Inclusion in this directory is not an endorsement.